Variant report
Variant | esv3480275 |
---|---|
Chromosome Location | chr8:4510269-4514315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149606312 | chr8:4510280-4510281 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571633397 | chr8:4510282-4510283 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185853739 | chr8:4510311-4510312 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539056052 | chr8:4510317-4510318 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143354493 | chr8:4510321-4510322 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139329013 | chr8:4510351-4510352 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536851443 | chr8:4510357-4510358 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554894117 | chr8:4510372-4510373 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192372617 | chr8:4510373-4510374 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536298229 | chr8:4510374-4510375 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs55929127 | chr8:4510379-4510380 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs147455013 | chr8:4510380-4510381 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183680271 | chr8:4510390-4510391 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543811828 | chr8:4510397-4510398 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188679935 | chr8:4510416-4510417 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190629592 | chr8:4510417-4510418 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182821212 | chr8:4510419-4510420 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187105925 | chr8:4510437-4510438 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527497415 | chr8:4510446-4510447 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76117540 | chr8:4510447-4510448 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191539933 | chr8:4510458-4510459 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532541885 | chr8:4510476-4510477 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550744746 | chr8:4510477-4510478 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139921140 | chr8:4510480-4510481 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375988854 | chr8:4510491-4510492 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558875345 | chr8:4510533-4510534 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141842452 | chr8:4510554-4510555 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150630811 | chr8:4510587-4510588 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559528693 | chr8:4510588-4510589 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534131688 | chr8:4510590-4510591 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558787368 | chr8:4510592-4510593 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs117649334 | chr8:4510603-4510604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557625681 | chr8:4510606-4510607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537442392 | chr8:4510609-4510610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79930203 | chr8:4510647-4510648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2725074 | chr8:4510670-4510671 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs114618900 | chr8:4510683-4510684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375790385 | chr8:4510687-4510688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561089027 | chr8:4510706-4510707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560214448 | chr8:4510754-4510755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374104639 | chr8:4510759-4510760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139790515 | chr8:4510789-4510790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371041725 | chr8:4510864-4510865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546060883 | chr8:4510885-4510886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572521272 | chr8:4510902-4510903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12114376 | chr8:4510932-4510933 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs149711455 | chr8:4510951-4510952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114136466 | chr8:4510980-4510981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530143987 | chr8:4510983-4510984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562707560 | chr8:4511020-4511021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4509600-4510600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr8:4510000-4510600 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr8:4510000-4510600 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:4510200-4510800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:4510600-4514400 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr8:4511400-4511600 | Enhancers | Adipose Nuclei | Adipose |
7 | chr8:4511600-4512000 | Flanking Active TSS | Adipose Nuclei | Adipose |
8 | chr8:4512000-4512200 | Enhancers | Adipose Nuclei | Adipose |